UNSPSC 51341803: Darunavir ethanolate

This classification denotes a protease inhibitor C27H37N3O7S.C2H6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33O78XF0BW, chemically known as ((1s,2r)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)- carbamic acid (3r,3as,6ar)-hexahydrofuro(2,3-b)furan-3-yl ester monoethanolate, but more generally known as darunavir ethanolate, which bears US NIH Compound Identifier 23725083.

UNSPSC 51341803 Darunavir ethanolate is a Commodity code that nominally covers a specific antiretroviral pharmaceutical product, but recent state and local opportunities tagged under this code show little alignment with that narrow scope. The opportunities instead reflect procurement of a broader range of pharmaceuticals, medical supplies, and pharmacy benefit programs — naloxone and drug deactivation systems for public health, medical and first aid supplies for emergency response, generic multi-source medications through cooperative purchasing, and direct-to-manufacturer pharmacy initiatives. Issuing bodies include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across multiple jurisdictions including Oregon). The geographic spread of recent activity spans Florida, Texas, Minnesota, and Oregon, with activity concentrated in state-administered cooperative purchasing vehicles and county or city procurement offices managing health, emergency response, and pharmacy benefit functions.

Recent representative opportunities include Seminole County, Florida's IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually (IFB60459723LAS, due Jul 26, 2023); the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000.00, with a five percent bid discount for certified Small Local Business Enterprises (26P00145, due Mar 13, 2026); the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due Mar 26, 2026 (S1070000015802); and the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescription programs (HHS0017013, posted Apr 3, 2026). The code exhibits limited relevance to its nominal darunavir ethanolate scope and instead captures a fragmented marketplace of emergency medical supplies, public health consumables, and pharmacy benefit consolidation across disparate state and local jurisdictions.